Amgen, medical centers diverge on potential conflicts in FDA pilot to speed early drug trials

FDA pilot program to accelerate first-in-human trials gets input from Amgen, MSK, Cleveland Clinic on QRI roles, conflicts of interest, and oversight timelines.

Raccontata daendpoints.news